UA81052C2 - Use of bicyclo [2.2.1] heptane derivatives for the preparation of neuroprotective pharmaceutical compositions for the reduction of the consequences of ischemic or traumatic brain and spinal damage - Google Patents

Use of bicyclo [2.2.1] heptane derivatives for the preparation of neuroprotective pharmaceutical compositions for the reduction of the consequences of ischemic or traumatic brain and spinal damage Download PDF

Info

Publication number
UA81052C2
UA81052C2 UAA200600574A UAA200600574A UA81052C2 UA 81052 C2 UA81052 C2 UA 81052C2 UA A200600574 A UAA200600574 A UA A200600574A UA A200600574 A UAA200600574 A UA A200600574A UA 81052 C2 UA81052 C2 UA 81052C2
Authority
UA
Ukraine
Prior art keywords
phenyl
heptane
general formula
trimethylbicyclo
pharmaceutically acceptable
Prior art date
Application number
UAA200600574A
Other languages
English (en)
Ukrainian (uk)
Inventor
Istvan Gacsalyi
Gabor Gigler
Gyorgy Levai
Annamaria Szimo
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egyt Gyogyszervegyeszeti Gyar filed Critical Egyt Gyogyszervegyeszeti Gyar
Publication of UA81052C2 publication Critical patent/UA81052C2/uk

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
UAA200600574A 2003-06-23 2004-06-22 Use of bicyclo [2.2.1] heptane derivatives for the preparation of neuroprotective pharmaceutical compositions for the reduction of the consequences of ischemic or traumatic brain and spinal damage UA81052C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU0301906A HUP0301906A3 (en) 2003-06-23 2003-06-23 Use of bicyclo[2.2.1]heptane derivatives for producing of pharmaceutical compositions having neuroprotectiv activity
PCT/HU2004/000062 WO2004112769A1 (en) 2003-06-23 2004-06-22 Use of bicyclo[2.2.1]heptane derivatives for the preparation of neuroprotective pharmaceutical compositions

Publications (1)

Publication Number Publication Date
UA81052C2 true UA81052C2 (en) 2007-11-26

Family

ID=90001689

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200600574A UA81052C2 (en) 2003-06-23 2004-06-22 Use of bicyclo [2.2.1] heptane derivatives for the preparation of neuroprotective pharmaceutical compositions for the reduction of the consequences of ischemic or traumatic brain and spinal damage

Country Status (23)

Country Link
US (1) US20060258750A1 (hu)
EP (1) EP1660063A1 (hu)
JP (1) JP2007516165A (hu)
KR (1) KR20060023997A (hu)
CN (1) CN1812778A (hu)
AU (1) AU2004248982A1 (hu)
BG (1) BG109414A (hu)
BR (1) BRPI0411772A (hu)
CA (1) CA2529254A1 (hu)
CZ (1) CZ200631A3 (hu)
EA (1) EA010868B1 (hu)
HR (1) HRP20060023A2 (hu)
HU (1) HUP0301906A3 (hu)
IL (1) IL172408A0 (hu)
IS (1) IS8239A (hu)
MX (1) MXPA05014127A (hu)
NO (1) NO20060277L (hu)
PL (1) PL378630A1 (hu)
RS (1) RS20050954A (hu)
SK (1) SK50082006A3 (hu)
UA (1) UA81052C2 (hu)
WO (1) WO2004112769A1 (hu)
ZA (1) ZA200510138B (hu)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2248524A3 (en) 2004-08-25 2011-03-09 Takeda Pharmaceutical Company Limited Preventives/remedies for stress urinary incontinence and method of screening the same
EP2742936A1 (en) 2006-05-16 2014-06-18 Takeda Pharmaceutical Company Limited Fused heterocyclic compound and use thereof
US20100266504A1 (en) 2007-11-15 2010-10-21 Takahiro Matsumoto Condensed pyridine derivative and use thereof
CZ2008602A3 (cs) * 2008-10-09 2009-11-25 Ústav chemických procesu Akademie ved Ceské republiky Zpusob a zarízení pro izolaci kyseliny tereftalové
EP2510949A4 (en) 2009-12-11 2013-11-13 Astellas Pharma Inc THERAPEUTICS FOR FIBROMYALGIA
US11478467B2 (en) 2017-05-04 2022-10-25 Sreenivasarao Vepachedu Targeted drug rescue with novel compositions, combinations, and methods thereof
EP3733204A4 (en) 2017-12-27 2021-09-15 Takeda Pharmaceutical Company Limited THERAPEUTIC FOR EXERCISE INCONTINENCE AND STAIR INCONTINENCE

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU227114B1 (en) * 1999-05-11 2010-07-28 Egis Gyogyszergyar Nyilvanosan (1r, 2s, 4r)-(-)-2-[n,n-(dimethylamino-ethoxy)]-2-phenyl-1,7,7-trimethyl-bicyclo[2.2.1]heptane of high purity and pharmaceutically acceptable acid addition salts thereof, process for preparation of them and medicaments containing the same
US6335371B1 (en) * 2000-11-28 2002-01-01 Orion Corporation Method for inducing cognition enhancement
HUP0103017A3 (en) * 2001-07-18 2004-05-28 Egis Gyogyszergyar Nyilvanosan Pharmaceutical composition for the treatment of diseases caused by impairment of cognitive functions and its use

Also Published As

Publication number Publication date
US20060258750A1 (en) 2006-11-16
IL172408A0 (en) 2006-04-10
NO20060277L (no) 2006-01-19
EP1660063A1 (en) 2006-05-31
MXPA05014127A (es) 2006-02-24
BRPI0411772A (pt) 2006-08-08
KR20060023997A (ko) 2006-03-15
PL378630A1 (pl) 2006-05-15
AU2004248982A1 (en) 2004-12-29
HUP0301906A3 (en) 2006-03-28
BG109414A (bg) 2006-11-30
CA2529254A1 (en) 2004-12-29
HUP0301906D0 (en) 2003-08-28
RS20050954A (en) 2007-08-03
JP2007516165A (ja) 2007-06-21
HUP0301906A2 (en) 2006-02-28
CN1812778A (zh) 2006-08-02
SK50082006A3 (sk) 2006-05-04
WO2004112769A1 (en) 2004-12-29
IS8239A (is) 2006-01-18
ZA200510138B (en) 2007-03-28
CZ200631A3 (cs) 2006-05-17
HRP20060023A2 (en) 2006-05-31
EA200600022A1 (ru) 2006-08-25
EA010868B1 (ru) 2008-12-30

Similar Documents

Publication Publication Date Title
JP5973411B2 (ja) 医薬組成物
CN103547260B (zh) 用于治疗中枢系统疾病的包含Brexpiprazole或其盐和第二种药物的组合
US20090023744A1 (en) Combination therapy for depression
KR20080044214A (ko) 이중층의 지속 방출형 경구 투여 조성물
JP2005505539A (ja) パーキンソン病の治療のためのcb1受容体アンタゴニストと、脳のドーパミン作用性神経伝達を活性化する製品を含む組成物
TW200418460A (en) Methods of using and compositions comprising a JNK inhibitor for the treatment, prevention, management and/or modification of pain
JP2024507991A (ja) 激越を処置するための方法及び組成物
BG109414A (bg) Използване на бицикло [2.2.1] хептанови производни за получаването на неврозащитни фармацевтични състави
MX2014015310A (es) Agente profilactico y/o terapeutico para el deterioro cognoscitivo leve.
EP4103187A1 (en) Methods of treating pseudobulbar affect and other emotional disturbances
PL196479B1 (pl) Zastosowanie saredutantu i jego farmaceutycznie dopuszczalnych soli do wytwarzania leków
EA015483B1 (ru) ПРИМЕНЕНИЕ ИНГИБИТОРА p38 КИНАЗЫ ДЛЯ ЛЕЧЕНИЯ ПСИХИАТРИЧЕСКИХ РАССТРОЙСТВ
CA3222959A1 (en) Naltrexone for boosting the therapeutic utility of 5-ht receptor agonists
HRP20010741A2 (en) Use of osanetant in the production of medicaments used to treat mood disorders
JP5386478B2 (ja) パーキンソン病に伴う運動不全の治療のための4−シクロプロピルメトキシ−n−(3,5−ジクロロ−1−オキシドピリジン−4−イル)−5−(メトキシ)ピリジン−2−カルボキサミドの使用
JP2004537548A (ja) 認知機能の減衰及び/又は損傷を治療するための医薬組成物
JPH08504203A (ja) パーキンソン病およびその進行を治療する薬剤の製造のためのイダゾキサンおよびその誘導体の使用
JP7048629B2 (ja) 医薬組成物およびその使用
KR101460828B1 (ko) 두개골 외상의 치료를 위한 4-시클로프로필메톡시-n-(3,5-디클로로-1-옥시도피리딘-4-일)-5-(메톡시)피리딘-2-카르복스아미드의 용도
JP2002524507A (ja) 新規組成物
JP2002524508A (ja) 新規組成物